Quantitative analysis of skeletal symmetric chlorhexidine in rat plasma using doubly charged molecular ions in LC-MS/MS detection

Bioanalysis

Volumn 3, Issue 12, 2011, Pages 1357-1368

  Pan, Jiongwei ^a,b   Fair, Sarah J ^a,c   Mao, Dunmin ^d  

^a CHARLES RIVER LABORATORIES   (United States)

^b Bioanalytical Services   (United States)

^c Thermo Fisher Scientific   (United States)

^d Maxxam Analytics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; ION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; EXTRACTION; HIGH THROUGHPUT SCREENING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; CHLORHEXIDINE; CHROMATOGRAPHY, LIQUID; LIMIT OF DETECTION; RATS; TANDEM MASS SPECTROMETRY;

EID: 79959384872     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.85     Document Type: Article

References (28)

1. Cousido MC, García-Caballero L, Limeres J, Álvarez M, Diz P. In vivo substantivity of 0.12% and 0.2% chlorhexidine mouthrinses on salivary bacteria. Clin. Oral Invest. 14(4), 397-402 (2010).
2. Lanzós I, Herrera D, Santos S, et al. Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse. Med. Oral Patol. Oral Cir. Bucal. 15(5), e732- e738 (2010).
3. Darouiche RO, Wall MJ Jr, Itani KMF, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl J. Med. 362(1), 18-26 (2010).
4. Stanislawczuk R, Amaral RC, Zander- Grande C, Gagler D, Reis A, Loguercio AD. Chlorhexidine-containing acid conditioner preserves the longevity of resin-dentin bonds. Oper. Dent. 34(4), 481-490 (2009).
5. Brackett MG, Tay FR, Brackett WW, Dib A, Dipp FA, Mai S, Pashley DH. In vivo chlorhexidine stabilization of hybrid layers of an acetone-based dentin adhesive. Oper. Dent. 34(4), 379-383 (2009).
6. Musial W, Mielck JB. The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol. AAPS PharmSciTech 10(3), 1048-1057 (2009).
7. Giannelli M, Chellini F, Margheri M, Tonelli P, Tani P. Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural investigation. Toxicol. In vitro 22(2), 308-317 (2008). (Pubitemid 351163536)
8. de Souza LB, de Aquino SG, de Souza PP, Hebling J, Costa CA. Cytotoxic effects of different concentrations of chlorhexidine. Am. J. Dent. 20(6), 400-404 (2007).
9. Pucher JJ, Daniel JC. The effects of chlorhexidine digluconate on human fibroblasts in vitro. J. Periodontol. 63(6), 526-532 (1992).
10. Lessa FC, Aranha AM, Nogueira I, Giro EM, Hebling J, Costa CA. Toxicity of chlorhexidine on odontoblasts-like cells. J. Appl. Oral Sci. 18(1), 50-58 (2010).
11. Lessa FC, Nogueira I, Huck C, Hebling J, Costa CA. Transdentinal cytotoxic effects of different concentrations of chlorhexidine gel applied on acid-conditional dentin substrate. J. Biomed. Mater. Res. B Appl. Biomater. 92(1), 40-47 (2010).
12. Goon AT, White IR, Rycroft RJ, MaFadden JP. Allergic contact dermatitis from chlorhexidine. Dermatitis 15(1), 45-47 (2004). (Pubitemid 38788586)
13. Sharma A, Chopra H. Chlorhexidine urticaria: a rare occurrence with a common mouthwash. Indian J. Dent. Res. 20(3), 377-379 (2009).
14. US Environmental Protection Agency. R.E.D. Facts. Reregistration Eligibility Decision, EPA-738-F-96-025. 1-5 (1996).
15. US FDA. Tolerances For Residues of New Animal Drugs in Food: Chlorhexidine. Code of Federal Regulations Title 21. Washington, DC, USA: Office of the Federal Register National Archives and Records Administration, 556, 120(2005).
16. Middleton JR, Herbert VR, Fox LK, Tomaszewska E, Lakritz J. Elimination kinetics of chlorhexidine in milk following intramammary infusion to stop lactation in mastitic mammary gland quarters of cows. J. Am. Vet. Med. Assoc. 222(12), 1746-1749 (2003). (Pubitemid 36693469)
17. Fiorentino FAM, Correa MA, Salgado HRN. Analytical methods for the determination of chlorhexidine: a review. Critical Reviews in Analytical Chemistry 40(2), 89-101 (2010).
18. Herbert VR, Middleton JR, Tomaszewska E, Fox LK. Methodology for quantifying residues of chlorhexidine in raw dairy milk. J. Agric. Food Chem. 51(3), 567-570 (2003).
19. Xue Y, Tang M, Hieda Y, et al. High-performance liquid chromatographic determination of chlorhexidine in whole blood by solid-phase extraction and kinetics following an intravenous infusion in rats. J. Anal. Toxicol. 33(2), 85-91 (2009).
20. Kudo K, Ikeda N, Kiyoshima A, Hino Y, Nishida N, Inoue N. Toxicological analysis of chlorhexidine in human serum using HPLC on a polymer-coated ODS column. J. Anal. Toxicol. 26(2), 119-122 (2002) (Pubitemid 34195167)
21. Havlíková L, Matysová L, Nováková L, Hájková P, Solich P. HPLC determination of chlorhexidine gluconate and p-chloroaniline in topical ointment. J. Pharm. Biomed. Anal. 43(3), 1169-1173 (2007). (Pubitemid 46185814)
22. Usui, K, Hishinuma T, Yamaguchi H, Tachiiri N, Goto J. Determination of chlorhexidine (CHD) and nonylphenolethoxylates (NPEOn) using LC-ESI-MS method and application hemolyzed blood. J. Chromatogr. B. 831(1-2), 105-109 (2006). (Pubitemid 43155783)
23. US FDA. Guidance for Industry: Bioanalytical Method Validation; US Department of Health and Human Services, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Rockville, MA, USA (2001).
24. Tuthill CW, Rudolph A, Li Y, et al. Quantitative analysis of thymosin a1 in human serum by LC-MS/MS. AAPS PharmSciTech 1(2), article 11 (2000).
25. Pan J, Jiang J, Chen YL. Automatic supported liquid extraction (SLE) coupled with HILIC LC-MS/MS: an application to method development and validation of erlotinib in human plasma. Pharmaceutics 2(2), 105-118 (2010).
26. Viswanathan CT, Bansal S, Booth B, et al. Workshop/conference report - quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E42 (2007) (Pubitemid 46296546)
27. Fast DM, Kelley M, Viswanathan CT, et al. Workshop report and follow-up - APPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples - implications of crystal city recommendations. AAPS J. 11(2), 238-241 (2009).
28. Savoie N, Booth BP, Bradley T, et al. The 2nd calibration and validation group workshop on recent issues in good laboratory practice bioanalysis. Bioanalysis 1(1), 19-30 (2009).